Perturbation biology links temporal protein changes to drug responses in a melanoma cell line

Area of Science:

• Systems Biology
• Cancer Research
• Pharmacology

Background:

• Cancer cells evade natural death and control mechanisms through altered intracellular protein signaling.
• Targeted cancer drugs often face resistance, necessitating combination therapies.
• Selecting effective drug combinations requires understanding complex signaling pathways, including feedback loops and crosstalk.

Purpose of the Study:

• To infer quantitative pathway models from time-resolved perturbation data in melanoma cells.
• To identify novel drug combinations that can overcome or prevent drug resistance.
• To demonstrate the utility of integrating time-resolved data with mathematical modeling for drug discovery.

Main Methods:

• Collected time-series data (10 minutes to 67 hours) on 124 (phospho-)protein levels and cell phenotypes (growth, apoptosis) after perturbing a melanoma cell line with 54 drug combinations.
• Trained time-resolved mathematical models to capture molecular interactions and their link to cellular phenotypes.
• Used systematic model simulations to predict effective drug combinations.

Main Results:

• Developed models that quantitatively represent molecular interactions and their coupling to cellular phenotype.
• Identified direct and indirect molecular responses to individual drugs.
• Predicted novel drug combinations that significantly reduce melanoma cell survival, with partial experimental validation.

Conclusions:

• Time-resolved data combined with mathematical modeling is a powerful approach for discovering new cancer drug combinations.
• This strategy can reveal key molecular responses and predict synergistic drug effects.
• The findings support the potential of perturbation biology for advancing targeted cancer therapy.